700EGP
- Active ingredient
- vinorelbine
- Strength
- 10 mg
- Form
- vial
- Manufacturer
- pierre - fabre france > egyptian pharmaceutical trading company
- Route
- injection
Uses
Antineoplastic agent used for locally advanced or metastatic non-small cell lung cancer. It may be used alone or with other chemotherapy agents.
Do not use if
No absolute contraindications are commonly listed, but use is inappropriate in patients with severe hypersensitivity to the drug.
Side effects
Myelosuppression, infection risk, constipation, nausea, neuropathy, hepatic toxicity, and injection-site injury may occur.
Warnings
Severe myelosuppression may lead to serious infection, hospitalization, or death. Blood counts should be monitored closely.
How it works
A vinca alkaloid that disrupts microtubule assembly and inhibits mitosis, leading to antitumor activity.
Storage
Store refrigerated at 2–8°C. Do not freeze and protect from light.